
Jean P. Cornet
Examiner (ID: 12155, Phone: (571)270-7669 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1628, 1614 |
| Total Applications | 1472 |
| Issued Applications | 565 |
| Pending Applications | 145 |
| Abandoned Applications | 815 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18451392
[patent_doc_number] => 20230192670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => ACID ADDITION SALTS OF BENZIMIDAZOLE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/990806
[patent_app_country] => US
[patent_app_date] => 2022-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17990806
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/990806 | Acid addition salts of benzimidazole derivative | Nov 20, 2022 | Issued |
Array
(
[id] => 18503565
[patent_doc_number] => 11701355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)
[patent_app_type] => utility
[patent_app_number] => 18/057116
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 44
[patent_no_of_words] => 26500
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057116
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057116 | Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF) | Nov 17, 2022 | Issued |
Array
(
[id] => 18295177
[patent_doc_number] => 20230104863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => METHODS FOR IMPROVED ENDOVASCULAR THROMBECTOMY USING 3,3'-DIINDOLYLMETHANE
[patent_app_type] => utility
[patent_app_number] => 18/054111
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054111
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/054111 | Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane | Nov 8, 2022 | Issued |
Array
(
[id] => 18281384
[patent_doc_number] => 20230096856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => COMBINED TREATMENT REGIMEN OF ANESTHESIA/SEDATION WITH ADMINISTRATION OF PSYCHEDELIC DRUGS ASSOCIATED WITH REDUCTION IN NEUROPSYCHIATRIC ILLNESS
[patent_app_type] => utility
[patent_app_number] => 17/935839
[patent_app_country] => US
[patent_app_date] => 2022-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17935839
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/935839 | COMBINED TREATMENT REGIMEN OF ANESTHESIA/SEDATION WITH ADMINISTRATION OF PSYCHEDELIC DRUGS ASSOCIATED WITH REDUCTION IN NEUROPSYCHIATRIC ILLNESS | Sep 26, 2022 | Abandoned |
Array
(
[id] => 18251867
[patent_doc_number] => 20230078906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => SUSTAINED RELEASE DEXAMETHASONE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/948842
[patent_app_country] => US
[patent_app_date] => 2022-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17948842
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/948842 | SUSTAINED RELEASE DEXAMETHASONE FORMULATION | Sep 19, 2022 | Abandoned |
Array
(
[id] => 18222140
[patent_doc_number] => 20230061134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHODS AND COMPOSITIONS FOR STIMULATION AND ENHANCEMENT OF REGENERATION OF TISSUES
[patent_app_type] => utility
[patent_app_number] => 17/933598
[patent_app_country] => US
[patent_app_date] => 2022-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17933598
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/933598 | METHODS AND COMPOSITIONS FOR STIMULATION AND ENHANCEMENT OF REGENERATION OF TISSUES | Sep 19, 2022 | Pending |
Array
(
[id] => 18962828
[patent_doc_number] => 11896567
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Combination composition
[patent_app_type] => utility
[patent_app_number] => 17/943708
[patent_app_country] => US
[patent_app_date] => 2022-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1695
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17943708
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/943708 | Combination composition | Sep 12, 2022 | Issued |
Array
(
[id] => 18140392
[patent_doc_number] => 20230014231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => METHODS FOR TREATING NEUTROPENIA
[patent_app_type] => utility
[patent_app_number] => 17/941509
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941509
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/941509 | Methods for treating neutropenia | Sep 8, 2022 | Issued |
Array
(
[id] => 18279816
[patent_doc_number] => 20230095288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METAL SALTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/821699
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821699
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821699 | Metal salts and uses thereof | Aug 22, 2022 | Issued |
Array
(
[id] => 19032423
[patent_doc_number] => 20240082238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/890757
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890757
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/890757 | COMPOSITIONS AND METHODS FOR TREATING CANCER | Aug 17, 2022 | Pending |
Array
(
[id] => 18550733
[patent_doc_number] => 20230248733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/890130
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890130
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/890130 | HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS | Aug 16, 2022 | Pending |
Array
(
[id] => 18434235
[patent_doc_number] => 20230181529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA
[patent_app_type] => utility
[patent_app_number] => 17/889029
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17889029
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/889029 | PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA | Aug 15, 2022 | Abandoned |
Array
(
[id] => 20039120
[patent_doc_number] => 20250177342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => HYDROXYPENTYL BENZOIC ACID DIESTER COMPOUND, AND PREPARATION METHOD AND PHARMACEUTICAL APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/271036
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271036
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/271036 | Hydroxypentyl benzoic acid diester compound, and preparation method and pharmaceutical application thereof | Aug 14, 2022 | Issued |
Array
(
[id] => 20039120
[patent_doc_number] => 20250177342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => HYDROXYPENTYL BENZOIC ACID DIESTER COMPOUND, AND PREPARATION METHOD AND PHARMACEUTICAL APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/271036
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271036
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/271036 | Hydroxypentyl benzoic acid diester compound, and preparation method and pharmaceutical application thereof | Aug 14, 2022 | Issued |
Array
(
[id] => 20039120
[patent_doc_number] => 20250177342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => HYDROXYPENTYL BENZOIC ACID DIESTER COMPOUND, AND PREPARATION METHOD AND PHARMACEUTICAL APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/271036
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271036
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/271036 | Hydroxypentyl benzoic acid diester compound, and preparation method and pharmaceutical application thereof | Aug 14, 2022 | Issued |
Array
(
[id] => 19947034
[patent_doc_number] => 12318372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Formulations with enhanced SN-38 solubility and oral absorption
[patent_app_type] => utility
[patent_app_number] => 17/882458
[patent_app_country] => US
[patent_app_date] => 2022-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 13
[patent_no_of_words] => 4506
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17882458
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/882458 | Formulations with enhanced SN-38 solubility and oral absorption | Aug 4, 2022 | Issued |
Array
(
[id] => 18034555
[patent_doc_number] => 20220378770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => DOSING REGIMENS FOR 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE
[patent_app_type] => utility
[patent_app_number] => 17/881874
[patent_app_country] => US
[patent_app_date] => 2022-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17881874
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/881874 | Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Aug 4, 2022 | Issued |
Array
(
[id] => 19716101
[patent_doc_number] => 12201616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Methods and compositions for treatment of mydriasis
[patent_app_type] => utility
[patent_app_number] => 17/877564
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 45186
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17877564
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/877564 | Methods and compositions for treatment of mydriasis | Jul 28, 2022 | Issued |
Array
(
[id] => 19716100
[patent_doc_number] => 12201615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Methods and compositions for treatment of mydriasis
[patent_app_type] => utility
[patent_app_number] => 17/877558
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 45289
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17877558
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/877558 | Methods and compositions for treatment of mydriasis | Jul 28, 2022 | Issued |
Array
(
[id] => 18034536
[patent_doc_number] => 20220378751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => INHIBITING DIHYDROFOLATE REDUCTASE IN A MICROORGANISM
[patent_app_type] => utility
[patent_app_number] => 17/870855
[patent_app_country] => US
[patent_app_date] => 2022-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17870855
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/870855 | INHIBITING DIHYDROFOLATE REDUCTASE IN A MICROORGANISM | Jul 21, 2022 | Abandoned |